ESI Group SA header image

ESI Group SA

ESI

Equity

ISIN FR0004110310 / Valor 955656

Euronext - Euronext Paris (2024-01-08)
EUR 154.00-0.32%

ESI Group SA
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

ESI Group SA, known by its Valor number 955656, is a publicly traded company. The stock of the company is available through the stock provider Euronext - Euronext Paris. As of 08.01.2024, the current price of the stock is EUR 154. The latest price change for this stock is -0.32%, which reflects the market’s response to various factors such as company performance, industry trends, and global economic conditions. The company has been evaluated by users of Umushroom, and has received a rating of 0 stars.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (13.06.2024):

Revenue Growth

In the first half of 2023, ESI Group SA reported a revenue increase of 1.5% year-over-year, reaching €85.6 million. This growth was primarily driven by the licenses segment, which contributed €78.2 million, accounting for 91% of the total revenue for the period. The company also noted a significant increase in Annual Recurring Revenues, which rose by 8.7% to €81.5 million.

Profitability Maintenance

ESI Group SA maintained its profitability in the first half of 2023, with an adjusted EBIT of €26.5 million, representing a stable adjusted EBIT margin of 30.9%. This stability in earnings before interest and taxes highlights the company's ability to manage costs effectively in an inflationary environment.

Strong Cash Position

As of June 30, 2023, ESI Group SA strengthened its financial position, reporting a substantial increase in net cash to €35.8 million, up from just €0.6 million a year earlier. This improvement was supported by robust cash flow from operating activities, which totaled €31 million during the period.

Geographical Revenue Distribution

During the first half of 2023, ESI Group SA saw a slight shift in the geographical distribution of its revenue. The EMEA region contributed 51.7% of total revenues, Asia accounted for 32.2%, and the Americas remained stable at 16.0%. This distribution underscores the global nature of ESI Group's business and its diverse market presence.

Future Outlook

Looking ahead, ESI Group SA is optimistic about its future performance and remains committed to its strategic repositioning under the "OneESI 2024 - Focus to Grow" plan. The company is confident in achieving its multi-year targets, despite ongoing exclusive negotiations with Keysight for the acquisition of a controlling stake, which is subject to regulatory approvals.

Summarized from source with an LLMView Source

Key figures

105%1Y
229%3Y
%5Y

Performance

2.50%1Y
35.6%3Y
33.4%5Y

Volatility

Market cap

1028 M

Market cap (USD)

Daily traded volume (Shares)

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Pegasystems Inc
Pegasystems Inc Pegasystems Inc Valor: 503997
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.87%USD 54.65
Meta Platforms Inc
Meta Platforms Inc Meta Platforms Inc Valor: 14917609
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.22%USD 592.67
Rubean AG
Rubean AG Rubean AG Valor: 33095126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.54%EUR 5.00
Halozyme Therapeutics Inc
Halozyme Therapeutics Inc Halozyme Therapeutics Inc Valor: 1814799
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.76%USD 70.56
Tarsus Pharmaceuticals Inc
Tarsus Pharmaceuticals Inc Tarsus Pharmaceuticals Inc Valor: 57410241
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.71%USD 74.17
Sezzle Inc
Sezzle Inc Sezzle Inc Valor: 129105133
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.24%USD 50.97
PAR Technology Corporation
PAR Technology Corporation PAR Technology Corporation Valor: 960461
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.66%USD 36.70
Toast Inc
Toast Inc Toast Inc Valor: 113470913
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.31%USD 34.71
Sportradar Group AG
Sportradar Group AG Sportradar Group AG Valor: 113423966
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.33%USD 21.81
Duolingo Inc
Duolingo Inc Duolingo Inc Valor: 112404331
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.67%USD 178.27